Table 1.
Characteristic | Cirrhotic patients with VTE | Cirrhotic patients without VTE | P value |
---|---|---|---|
Number (%) | 6 (2.7%) | 220 (97.3%) | |
Age in years*, | 63.5(49-83.7) | 63(54-70) | 0.67 |
Sex | 0.57 | ||
Male, N (%) | 2 (33.3%) | 138 (62.7%) | |
Female, N (%) | 4 (66.6%) | 82 (37.3%) | |
INR* | 1.55(1.25-2.15) | 1.3(1.1-1.6) | 0.24 |
Patients admitted with INR≥ 1.8 | 1(16.6%) | 40(18.2%) | 1 |
APTT* | 36.75 (29.3-38) | 33(29-40) | 0.75 |
Platelet count/μL* | 201(122-265) | 136(81-206) | 0.12 |
Albumin (g/L)* | 26.5(23.5-32.2) | 30(26-35) | 0.23 |
Bilirubin (μmol/L)* | 28(14.7-209.4) | 37.4(18-85.5) | 0.88 |
Creatinine (μmol/L)* | 93(87.5-138.6) | 81(73-151) | 0.49 |
Etiology of liver cirrhosis Hepatitis B N (%) |
2 (33.3%) | 47 (21.3%) | 0.6 |
Hepatitis C N (%) | 3 (50.0%) | 112 (50.9%) | 1 |
Alcoholic N (%) | 0 | 0 | |
Autoimmune N (%) | 0 | 4 (1.8%) | |
Cryptogenic N (%) | 1 (16.6%) | 46 (20.9%) | |
Other N (%) | 0 | 16(7%) | |
Patients admitted with Infections | 2 (33%) | 119(54%) | 0.42 |
Bleeding | 2(33%) | 52(23.6%) | 0.63 |
Hepatocellular carcinoma N (%) | 1 (16.6%) | 100 (45.5%) | 0.22 |
Incidence of ICU admission N (%) | 2 (33.3%) | 45 (20.5%) | 0.6 |
Child-Pugh stage, mean ± SD | 10.3 ± 1.97 | 8.25 ± 2.57 | 0.052 |
Grade A N (%) | 0 | 70 (31.8%) | |
Grade B N (%) | 3 (50%) | 84 (38.2%) | 0.68 |
Grade C N (%) | 3 (50%) | 72 (32.7%) | 0.4 |
Hospital LOS*, | 43(12.3-75.5) | 8(4.25-14.7) | 0.004 |
Hospital mortality N (%) | 4 (66.6%) | 73 (33.2%) | 0.18 |
* Expressed as Median (Interquartile range)
INR: international normalized ratio
APPT: activated partial thromboplastin time
LOS: length of stay